12-Feb-2024 | Zion Market Research
Zion Market Research has published a new report titled “Viral Clearance Market Analysis By Method(Viral Removal (Chromatography, Precipitation, And Nanofiltration), Viral Inactivation (Low PH, Solvent Detergent Method, Pasteurization, And Other Viral Inactivation Methods)), By Application(Blood And Blood Products, Recombinant Proteins, Vaccines, And Other Applications), By End-User(Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CROs, And Other End-Users), And By Region: Global Industry Perspective, Comprehensive Analysis, And Forecast 2024-2032”. According to the report, the global viral clearance market was valued at approximately USD 726.31 million in 2023 and is expected to generate revenue of around USD 4,011.27 million by 2032, growing at a CAGR of around 20.91% between 2024 and 2032.
Biological products are prone to contamination with bacteria, fungi, and viruses. The source of contamination might be raw materials, improper culture handling, etc. Viral clearance is an important process during the downstream purification of therapeutic biologics, blood, and tissue-derived products. Viruses are either removed or inactivated. To produce microbiologically safe products, viral clearance plays a crucial role.
Browse the full "Viral Clearance Market Analysis By Method(Viral Removal (Chromatography, Precipitation, And Nanofiltration), Viral Inactivation (Low PH, Solvent Detergent Method, Pasteurization, And Other Viral Inactivation Methods)), By Application(Blood And Blood Products, Recombinant Proteins, Vaccines, And Other Applications), By End-User(Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CROs, And Other End-Users), And By Region: Global Industry Perspective, Comprehensive Analysis, And Forecast 2024-2032" Report At https://www.zionmarketresearch.com/report/viral-clearance-market
Recombinant proteins have high potency and lesser side effects. They mimic naturally occurring proteins and, hence, are widely used worldwide. Thus, the growth is observed in the biopharmaceutical research and development field. Advances and investments made in the biotechnology and pharmaceutical industries drive the viral clearance market. Additionally, favorable research funding and government grants for product development contribute notably toward this market’s growth. The need for virus clearance in cell culture to avoid contamination, high burden of chronic disorders, and increasing aging population are also likely to contribute toward the viral clearance market. The high cost of technology and the time-consuming process of drug development might hamper this market’s growth. Growing demand for contract research organizations for pharmaceutical outsourcing along with potential emerging markets are likely to present lucrative opportunities for the viral clearance market in the upcoming years.
The viral clearance market is divided based on viral clearance method, application, and end-user. The viral clearance method segment is categorized into viral removal and viral inactivation. Viral removal segment is sub-segmented into chromatography, precipitation, and nanofiltration based on virus removal technique. The viral inactivation segment is sub-segmented into low pH, solvent detergent method, pasteurization, and other viral inactivation methods. In the viral removal segment, nanofiltration held the largest market share in 2022. Chromatographic viral removal segment is expected to grow at the fastest CAGR. By application, the viral clearance market is segmented into blood and blood products, recombinant proteins, vaccines, and other applications. The other applications include stem cell products, cellular and gene therapy products, tissue and tissue products etc. The recombinant proteins application segment dominated the market in 2022, owing to increased production and use of biosimilars and other therapeutic proteins for treating life-threatening diseases, such as cancer, diabetes, etc., globally. By end-user, this market includes pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), and other end-users. The pharmaceutical and biotechnology companies segment dominated the viral clearance market in 2022 in terms of revenue share and is projected to lead during the forecast time period.
By region, the global viral clearance market is segmented into North America, Asia Pacific, the Middle East, and Africa, Europe, and Latin America. North America held the largest revenue share of about 42% in 2022 and is expected to maintain its position during the forecast time period. Factors promoting this regional market’s growth are growing biopharmaceutical research, favorable government funding, and huge research investments made by biopharmaceutical companies. High acceptance of biopharmaceutical products and increased spending on recombinant protein research are factors promoting this market’s growth in the European region. The Asia Pacific viral clearance market is growing rapidly, due to a large number of contract research organizations (CROs) in India and China, growth in generics and pharmaceutical manufacturing, and development in India, Malaysia, and Singapore. The Middle East and Africa market are likely to observe considerable growth in the upcoming years. Latin America is expected to witness moderate growth over the forecast time period.
Some key players operating in the viral clearance market include Merck KGaA, Wuxi Biologics (Cayman), Charles River Laboratories International Inc., Kedrion, Texcell Inc., Vironova Biosafety, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH, among others.
This report segments the global viral clearance market as follows:
Global Viral Clearance Market: By Method
Global Viral Clearance Market: By Application
Global Viral Clearance Market: By End-User
Global Viral Clearance Market: By Region
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed